ClinicalTrials.gov
ClinicalTrials.gov Menu

CholGate - The Effect of Alerting Versus on Demand Computer Based Decision Support on Treatment of Dyslipidaemia by General Practitioners

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00348751
Recruitment Status : Completed
First Posted : July 6, 2006
Last Update Posted : May 8, 2008
Sponsor:
Collaborator:
Dutch Heart Foundation
Information provided by:
Erasmus Medical Center

Brief Summary:
Indirect evidence show alerting physicians with clinical decision support systems (CDSS) seem to change behaviour more than requiring users to actively initiate the system. However, randomized trials comparing these methods in a clinical setting are lacking. In this study we compare the effect of Alerting physicians with a CDSS or actively requiring initiation of CDSS on the adherence of Dutch general practitioners to the Cholesterol guideline of the Dutch college of General Practitioners.

Condition or disease Intervention/treatment Phase
Decision Support Systems, Clinical Device: CholGate Not Applicable

Detailed Description:
Indirect evidence show alerting physicians with clinical decision support systems (CDSS) seem to change behaviour more than requiring users to actively initiate the system. However, randomized trials comparing these methods in a clinical setting are lacking. In this study we compare the effect of Alerting physicians with a CDSS or actively requiring initiation of CDSS on the adherence of Dutch general practitioners to the Cholesterol guideline of the Dutch college of General Practitioners, using a clinical decsion support system called CholGate. This system has the functionality to provide both Alerting and On-Demand decision support. Users are free to negate the advise provided by the decision support system. The trial will have a cluster randomized structure.

Study Type : Interventional  (Clinical Trial)
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Official Title: The Effect of Alerting Versus on Demand Computer Based Decision Support on Treatment of Dyslipidaemia by General Practitioners - The CholGate Randomized Trial
Study Start Date : June 2004
Study Completion Date : November 2005

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Caffeine
U.S. FDA Resources




Primary Outcome Measures :
  1. The percentage of correctly screened patients using anonymous patient record data.
  2. The percentage of correctly treated patients using anonymous patient record data.


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 70 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Criteria

Inclusion Criteria:

  • All general practices using only Elias electronic patient records (ISOFT b.V)
  • All patients meeting the screening and treatment criteria of the Dutch college of general practitioners cholesterol guideline

Exclusion Criteria:

  • Practices that used paper based records

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00348751


Locations
Netherlands
Department of Medical informatics, ErasmusMC
Rotterdam, South Holland, Netherlands, 3000DR
Sponsors and Collaborators
Erasmus Medical Center
Dutch Heart Foundation
Investigators
Principal Investigator: Jacobus T van Wyk, MD, PhD ErasmusMC University Medical Centre Rotterdam

Publications:

ClinicalTrials.gov Identifier: NCT00348751     History of Changes
Other Study ID Numbers: 2000B161
First Posted: July 6, 2006    Key Record Dates
Last Update Posted: May 8, 2008
Last Verified: June 2006

Additional relevant MeSH terms:
Dyslipidemias
Lipid Metabolism Disorders
Metabolic Diseases